The role of Wnt pathway in the pathogenesis of OA and its potential therapeutic implications in the field of regenerative medicine
Food and Drug Administration is not recommended during pregnancy, a designation that indicates animal studies have shown adverse effects, but human pregnancy data does not exist
12 linked COA previews are available for this series
Michael Brines at The Feinstein Institute for Medical Research, Northwell Health, New York), ARA-290 was specifically engineered to dissociate erythropoietins two major functional activities: Erythropoiesis (red blood cell stimulation driven by EPOR homodimer activation) eliminated in ARA-290 Tissue protection and repair (anti-inflammatory, anti-apoptotic, neuroprotective driven by IRR activation) selectively retained in ARA-290 This elegant dissociation is the core of ARA-290s research significance
For women, this raises additional concerns about exposure during sensitive life stages (e.g., pregnancy, postpartum, perimenopause)